Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MVL

Crystal structure of VISTA bound to a pH-selective antibody Fab fragment

Summary for 6MVL
Entry DOI10.2210/pdb6mvl/pdb
DescriptorV-type immunoglobulin domain-containing suppressor of T-cell activation, Antibody Fab fragment heavy chain, Antibody Fab fragment light chain, ... (6 entities in total)
Functional Keywordsimmunoglobulin, checkpoint, antibody, complex, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains3
Total formula weight68404.41
Authors
Critton, D.A. (deposition date: 2018-10-26, release date: 2019-10-23, Last modification date: 2024-10-23)
Primary citationJohnston, R.J.,Su, L.J.,Pinckney, J.,Critton, D.,Boyer, E.,Krishnakumar, A.,Corbett, M.,Rankin, A.L.,Dibella, R.,Campbell, L.,Martin, G.H.,Lemar, H.,Cayton, T.,Huang, R.Y.,Deng, X.,Nayeem, A.,Chen, H.,Ergel, B.,Rizzo, J.M.,Yamniuk, A.P.,Dutta, S.,Ngo, J.,Shorts, A.O.,Ramakrishnan, R.,Kozhich, A.,Holloway, J.,Fang, H.,Wang, Y.K.,Yang, Z.,Thiam, K.,Rakestraw, G.,Rajpal, A.,Sheppard, P.,Quigley, M.,Bahjat, K.S.,Korman, A.J.
VISTA is an acidic pH-selective ligand for PSGL-1.
Nature, 574:565-570, 2019
Cited by
PubMed Abstract: Co-inhibitory immune receptors can contribute to T cell dysfunction in patients with cancer. Blocking antibodies against cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 (PD-1) partially reverse this effect and are becoming standard of care in an increasing number of malignancies. However, many of the other axes by which tumours become inhospitable to T cells are not fully understood. Here we report that V-domain immunoglobulin suppressor of T cell activation (VISTA) engages and suppresses T cells selectively at acidic pH such as that found in tumour microenvironments. Multiple histidine residues along the rim of the VISTA extracellular domain mediate binding to the adhesion and co-inhibitory receptor P-selectin glycoprotein ligand-1 (PSGL-1). Antibodies engineered to selectively bind and block this interaction in acidic environments were sufficient to reverse VISTA-mediated immune suppression in vivo. These findings identify a mechanism by which VISTA may engender resistance to anti-tumour immune responses, as well as an unexpectedly determinative role for pH in immune co-receptor engagement.
PubMed: 31645726
DOI: 10.1038/s41586-019-1674-5
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.61 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon